Results 291 to 300 of about 202,276 (321)
Between Blood and Tumor: Retroperitoneal Hematoma Look-Alike Revealed as Diffuse Large B-Cell Lymphoma. [PDF]
Dar UA +4 more
europepmc +1 more source
ABSTRACT Background Low muscle oxidative capacity is an extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD) with unclear aetiology. We sought to characterize locomotor muscle oxidative capacity in never smokers and ever smokers with and without COPD and determine clinical and behavioural features associated with low muscle ...
Alessandra Adami +5 more
wiley +1 more source
ABSTRACT Introduction Polatuzumab vedotin (Pola) is an antibody‐drug conjugate approved for the treatment of diffuse large B‐cell lymphoma (DLBCL). Several reports suggest that the tumor microenvironment influences the outcome of DLBCL treatments; with Pola, however, the link between tumor microenvironment and treatment outcome remains unclear ...
Mayu Tomita +9 more
wiley +1 more source
Upper Gastrointestinal Bleeding Secondary to Gastric Invasion by Diffuse Large B-cell Lymphoma. [PDF]
Paglia H, Noriega M, Kher KR.
europepmc +1 more source
Primary thyroid diffuse large B-cell lymphoma: fine needle aspiration and histological correlation. [PDF]
Moon WS, Hong YT, Ahn AR.
europepmc +1 more source
Diffuse Large B-cell lymphoma in a Ras-Associated Autoimmune Leukoproliferative Disorder (RALD). [PDF]
Sun C +10 more
europepmc +1 more source
Redox destabilization by ibrutinib promotes ferroptosis in diffuse large B-cell lymphoma (DLBCL). [PDF]
Langpape A +6 more
europepmc +1 more source

